FDA: Pancreatic enzyme medically necessary

Pancreatic enzyme replacement products have been around for a long time, but have largely existed as nutritional supplements. Yesterday, an FDA official said the products are medically necessary, which might mean an approval is in store for Solvay's Creon. Creon and similar products aim to help patients with chronic pancreatitis, cystic fibrosis and other conditions that require replacement of pancreatic enzymes essential for digestion. Report

Free Webinar

What could you do with real-time supply chain information at your fingertips?

Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Register today!

Suggested Articles

Implementing data integration strategy in your commercialization breaks down traditional healthcare silos and improves patient outcomes.

Roche and Blueprint's RET inhibitor Gavreto has won FDA go-ahead to treat certain types of thyroid cancer, leveling the field with Lilly's Retevmo.

CDMO Sterling Pharma Solutions is plotting a buyout of a U.K.-based antibody-drug conjugate specialist in a new bid at the next-gen cancer fighters.